BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 98 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $365,000 | +49.0% | 282,972 | +21.3% | 0.00% | – |
Q3 2019 | $245,000 | -26.2% | 233,355 | +19.6% | 0.00% | – |
Q2 2019 | $332,000 | -63.5% | 195,132 | -27.7% | 0.00% | – |
Q1 2019 | $910,000 | +78.8% | 269,877 | +54.7% | 0.00% | – |
Q4 2018 | $509,000 | -57.5% | 174,458 | -10.4% | 0.00% | – |
Q3 2018 | $1,199,000 | +1.4% | 194,690 | +21.5% | 0.00% | – |
Q2 2018 | $1,182,000 | +341.0% | 160,181 | +292.2% | 0.00% | – |
Q1 2018 | $268,000 | -50.5% | 40,846 | -36.4% | 0.00% | – |
Q4 2017 | $541,000 | -37.5% | 64,230 | -14.4% | 0.00% | – |
Q3 2017 | $866,000 | -8.6% | 75,003 | -7.5% | 0.00% | – |
Q2 2017 | $947,000 | +0.9% | 81,065 | +6.6% | 0.00% | – |
Q1 2017 | $939,000 | +72.9% | 76,081 | +91.0% | 0.00% | – |
Q4 2016 | $543,000 | +137.1% | 39,839 | +245.7% | 0.00% | – |
Q3 2016 | $229,000 | +301.8% | 11,525 | +161.9% | 0.00% | – |
Q2 2016 | $57,000 | +23.9% | 4,400 | -11.2% | 0.00% | – |
Q1 2016 | $46,000 | -48.9% | 4,954 | +11.8% | 0.00% | – |
Q4 2015 | $90,000 | +40.6% | 4,430 | -0.1% | 0.00% | – |
Q3 2015 | $64,000 | -52.9% | 4,434 | -30.7% | 0.00% | – |
Q2 2015 | $136,000 | +655.6% | 6,394 | +699.2% | 0.00% | – |
Q1 2015 | $18,000 | – | 800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|